Article

Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019

Jayanthi Mathaiyan1★, Prasanth Ganesan2, Tamilarasu Kadhiravan3, Nishanthi Anandabaskar4★ Corresponding author

  1. 1Department of Pharmacology, JIPMER, Puducherry, India.
  2. 2Department of Medical Oncology, JIPMER, Puducherry, India.
  3. 3Department of Medicine, JIPMER, Puducherry, India.
  4. 4Department of Pharmacology, Sri Manakula Vinayagar Medical College Hospital, Puducherry, India.

CORRESPONDENCE

Jayanthi Mathaiyan

Department of Pharmacology, JIPMER, Puducherry, India.

drjayanthi2008@gmail.com

Received: 24-12-2020; Revised: 26-12-2020; Accepted: 29-12-2020.

Volume 11, Issue 4 · pp. 148–150 · PUBLISHED 2020 · DOI: 10.4103/jpp.jpp_173_20

View on JPP original site ↗

ABSTRACT

KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Mathaiyan, J., Ganesan, P., Kadhiravan, T., & Anandabaskar, N. (2020). Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019. Journal of Pharmacology and Pharmacotherapeutics, 11(4), 148–150. https://doi.org/10.4103/jpp.jpp_173_20